JSM 2005 - Toronto

JSM Activity #138

This is the preliminary program for the 2005 Joint Statistical Meetings in Minneapolis, Minnesota. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 7-10, 2005); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.



The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

The Program has labeled the meeting rooms with "letters" preceding the name of the room, designating in which facility the room is located:

Minneapolis Convention Center = “MCC” Hilton Minneapolis Hotel = “H” Hyatt Regency Minneapolis = “HY”

Back to main JSM 2005 Program page
Legend: = Applied Session, = Theme Session, = Presenter
Add To My Program
138 Applied Session Mon, 8/8/05, 10:30 AM - 12:20 PM MCC-102 A
QT and Randomization Issues - Contributed - Papers
Biopharmaceutical Section, WNAR
Chair(s): Thomas Liu, Amgen Global Biostatistics
     10:35 AM   Statistical Properties of Maximal Mean Change in Evaluating QT Prolongation — Genming Shi, Schering-Plough; Bo Yang, Schering-Plough; Ferdous Gheyas, Schering-Plough; Ramachandran Suresh, Schering-Plough
     10:50 AM   Dynamic Modeling of Beat-to-beat QT-RR Data Using the Bootstrap — Kimberly Crimin, Pfizer, Inc.
     11:05 AM   How Does Stratified Randomization Affect the Balance of a Clinical Trial? — Xiaohui Luo, Merck & Co., Inc.; Matilde Sanchez, Merck & Co., Inc.
     11:20 AM   Effects from Treatment Confounding Factors in Randomized Controlled Clinical Trials — Boll Wu, Sanofi-Aventis; Ray Zhu, Sanofi-Aventis
     11:35 AM   A Note on Postrandomization Covariates Adjustment — Minzhi Liu, Merck & Co., Inc.
     11:55 AM   Estimating the Response Rate when Measurements are Subject to Error — Yongming Qu, Eli Lilly and Company; Pandurang M. Kulkarni, Eli Lilly and Company
     12:05 PM   Impact of QT Correction Methods on the Assessment of QT Prolongation Potential of Drugs — Navdeep Boparai, Schering-Plough; Genming Shi, Schering-Plough; Ferdous Gheyas, Schering-Plough
 

JSM 2005 For information, contact jsm@amstat.org or phone (888) 231-3473. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2005